Application of Meridian flow injection acupoint application combined with transcutaneous electrical acupoint stimulation in patients undergoing gastroenteroscopy

Table 1 General information, n (%)

Group	n	Gender		Age (years)		Weight (kg)	Operation time (minute)	Disease diagnosis
		Male	Female					Gastric lesions	Colorectal lesions	Esophageal lesions
Observation group	60	37 (61.67)	23 (38.33)		56.93 ± 11.88	59.98 ± 6.35	54.85 ± 6.66	36 (60.00)	13 (21.67)	11 (18.33)
Control group	60	28 (46.67)	32 (53.33)		55.85 ± 12.89	59.70 ± 6.38	55.42 ± 5.41	40 (66.67)	14 (23.33)	6 (10.00)
χ2/t	-	2.719			0.479	0.244	0.512	1.718
P value	-	0.099			0.633	0.808	0.610	0.424

Table 2 Improvement in symptoms

Group	n	Recovery of bowel sounds	The time of first defecation	The first bowel movement	First feeding time	Hospitalisation time
Observation group	60	1.55 ± 0.57	1.87 ± 0.50	3.20 ± 1.04	2.55 ± 0.72	5.57 ± 0.89
Control group	60	1.65 ± 0.52	1.93 ± 0.36	3.98 ± 1.27	2.96 ± 0.82	6.30 ± 1.45
t	-	1.013	0.833	3.701	2.894	3.333
P value	-	0.313	0.406	0.001	0.005	0.001

Table 3 Expression levels of gastrin

Group	n	Gastrin (pg/mL)
		Before treatment	After 3 days of treatment
Observers	60	241.65 ± 25.61	161.15 ± 16.75
Control group	60	240.86 ± 26.84	205.33 ± 18.64
t	-	0.165	13.655
P value	-	0.869	< 0.001

Table 4 Excellent rate in both groups, n (%)

Group	n	Excellent	Good	Poor	Excellent rate
Observation group	60	40 (66.67)	16 (26.67)	4 (6.67)	56 (93.33)
Control group	60	30 (50.00)	15 (25.00)	15 (25.00)	45 (75.00)
χ2	-				7.566
P value	-				0.006

Table 5 Total satisfaction rate of patients in the two groups, n (%)

Group	n	Very satisfied	Satisfied	Generally dissatisfied	Unsatisfied	Overall satisfaction rate
Observation group	60	32 (53.33)	23 (38.33)	5 (8.33)	0 (0.00)	55 (91.67)
Control group	60	25 (41.67)	16 (26.67)	18 (30)	1 (1.67)	41 (68.33)
χ2	-					10.208
P value	-					0.001

Table 6 Postoperative stress in two groups of patients

Group	n	Norepinephrine (pg/mL)		Cortisol (μg/L)		Aldosterone (pg/mL)
		Before treatment	After 3 days of treatment	Before treatment	After 3 days of treatment	Before treatment	After 3 days of treatment
Observation group	60	256.64 ± 23.32	125.53 ± 17.78	275.32 ± 32.65	142.16 ± 19.55	68.64 ± 9.61	51.14 ± 5.39
Control group	60	256.79 ± 23.41	176.33 ± 19.85	275.76 ± 32.48	196.08 ± 17.44	68.71 ± 9.22	68.83 ± 4.47
t	-	0.035	14.766	0.074	15.942	0.041	19.569
P value	-	0.972	< 0.001	0.941	< 0.001	0.968	< 0.001